一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Pharmaceutical intermediates>Bulk Drug Intermediates>Ozagrel sodium
Ozagrel sodium
  • Ozagrel sodium
  • Ozagrel sodium
  • Ozagrel sodium

Ozagrel sodium

Price Get Latest Price
Package 1kg 25kg
Min. Order: 1kg
Supply Ability: 500kg
Update Time: 2025-12-25

Product Details

Product Name: Ozagrel sodium CAS No.: 130952-46-4
Min. Order: 1kg Purity: 0.99
Supply Ability: 500kg Release date: 2025/12/25

?? ?Product Overview?
?Ozagrel Sodium? (CAS: 130952-46-4) is a selective thromboxane A2 synthase inhibitor widely recognized for its antiplatelet activity, effectively preventing thrombus formation in cardiovascular conditions such as acute ischemic stroke and peripheral arterial occlusion. With a molecular formula of ?C??H??N?NaO?? and molecular weight of ?250.23?, this compound reduces platelet aggregation by over 80% in clinical studies. It is a critical component in ?pharmaceutical manufacturing?, ?clinical therapy?, and ?cardiovascular research?, supporting advanced treatments for thrombotic disorders.

? ?Key Advantages?
?? ?High Efficacy?: Clinically proven to reduce platelet aggregation by >80%.
?? ?Premium Quality?: ≥98% purity (HPLC/GC-certified), compliant with USP/EP standards.
?? ?Stability?: Stable under ambient storage with long-term shelf life.
?? ?Structural Verification?: Confirmed by NMR, MS, and chromatographic analysis.

?? ?Applications?
? ?Pharmaceuticals?: Key intermediate in antiplatelet drug formulations.
? ?Clinical Use?: Approved for ischemic stroke and thrombosis management.
? ?Research?: Investigated for neuroprotective and anti-inflammatory properties.

?? ?Quality Certifications?
? Complies with ?USP/EP? guidelines for impurities, heavy metals, and residual solvents.
? Batch-specific COA includes purity (≥98%), pH (8.0–9.5), and moisture content (≤0.5%).
? Rigorous testing via HPLC (>95% purity), NMR, and mass spectrometry.

?? ?Market Trends?
The global cardiovascular drug market is projected to grow at ?5.2% CAGR (2025–2030)?, driven by rising thrombosis and stroke prevalence. Ozagrel Sodium holds a significant share in antiplatelet APIs, with expanding demand in Asia-Pacific and Europe.

?Google Keywords?: Ozagrel Sodium CAS 130952-46-4, cardiovascular API, antiplatelet agent, USP/EP certified, pharmaceutical supplier.


Company Profile Introduction

Wuhan Biocar Pharmaceutical Co., Ltd. is a high-tech and innovative enterprise specializing in the research, development, production, and sales of APIs and pharmaceutical intermediates (excluding finished drugs). Located in the heart of Optics Valley Biological City, our company leverages the cutting-edge facilities of the Wuhan University Scientific Research Laboratory and benefits from the region's favorable policies to advance the field of biomedicine. Guided by our business philosophy—"Driven by market demand, powered by technological innovation, and enabled by e-commerce"—we are committed to delivering biomedical products that are precise, high-quality, fast, and reliable. Our offerings serve pharmaceutical companies, university research institutions, hospital outpatient services, reagent providers, and distributors worldwide.

You may like

Recommended supplier

Product name Price   Suppliers Update time
VIP9Y
Guangzhou PI PI BIOTECH INC
2025-12-19
PNP Biotech Co. Ltd
2024-03-28
$150.00
Hebei Mingeng Biotechnology Co., Ltd
2023-06-26
$100.00
Hebei Minshang Biological Technology Co. LTD
2021-05-22
$3.00
VIP7Y
Career Henan Chemical Co
2020-01-08
INQUIRY

+86-+undefined-+86 13343427080
sales@biocarchem.com
平武县| 高要市| 井冈山市| 平度市| 湖口县| 闵行区| 尼木县| 德惠市| 武威市| 微山县| 修文县| 礼泉县| 北京市| 葫芦岛市| 焦作市| 合川市| 皮山县| 广西| 凤阳县| 梓潼县| 南宁市| 饶平县| 清流县| 东丰县| 休宁县| 邯郸市| 龙陵县| 雅江县| 绥滨县| 大荔县| 江西省| 堆龙德庆县| 台南县| 和田县| 泰宁县| 祥云县| 正定县| 胶南市| 安仁县| 谢通门县| 清丰县|